DDInter948 DDInter1541
Human interferon beta (165 residues), cysteine 17 is substituted with serine. Produced in E. coli, no carbohydrates, MW=18.5kD
A thiourea antithyroid agent. Propythiouracil inhibits the synthesis of thyroxine and inhibits the peripheral conversion of throxine to tri-iodothyronine. It is used in the treatment of hyperthyroidism. (From Martindale, The Extra Pharmacopeoia, 30th ed, p534)
Propylthiouracil {u} (Compound) treats {v} (Disease) Graves' disease
Propylthiouracil {u} (Compound) binds {v} (Gene) MPO
Propylthiouracil {u} (Compound) upregulates {v} (Gene) WRB
Propylthiouracil {u} (Compound) is included by {v} (Pharmacologic Class) Thyroid Hormone Synthesis Inhibitors
Propylthiouracil {u} (Compound) downregulates {v} (Gene) EXOSC4
Propylthiouracil {u} (Compound) causes {v} (Side Effect) Traumatic liver injury
Propylthiouracil {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Macimorelin
Propylthiouracil {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Tioguanine
Propylthiouracil {u} may lead to a major life threatening interaction when taken with {v} Mipomersen
Propylthiouracil (Compound) treats Graves' disease (Disease)
Propylthiouracil (Compound) binds MPO (Gene)
Propylthiouracil (Compound) upregulates WRB (Gene)
Propylthiouracil (Compound) is included by Thyroid Hormone Synthesis Inhibitors (Pharmacologic Class)
Propylthiouracil (Compound) downregulates EXOSC4 (Gene)
Propylthiouracil (Compound) causes Traumatic liver injury (Side Effect)
Propylthiouracil may cause a moderate interaction that could exacerbate diseases when taken with Macimorelin
Propylthiouracil may cause a moderate interaction that could exacerbate diseases when taken with Tioguanine
Propylthiouracil may lead to a major life threatening interaction when taken with Mipomersen